Cellectis (CLLS) Misses Q3 EPS by 16c

Cellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.58), $0.16 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $1.88 million versus the consensus estimate of $3.58 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c